Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy

American Journal of Cardiology

Volumn 86, Issue 9, 2000, Pages 1036-1040

  Mizuno, Yuji ^a   Yoshimura, Michihiro ^a   Harada, Eisaku ^a   Nakayama, Masafumi ^a   Sakamoto, Tomohiro ^a   Shimasaki, Yukio ^a   Ogawa, Hisao ^a   Kugiyama, Kiyotaka ^a   Saito, Yoshihiko ^b   Nakao, Kazuwa ^b   Yasue, Hirofumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HEART DILATATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROBABILITY; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STROKE VOLUME;

EID: 0034332725     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01147-4     Document Type: Article

References (20)

1. Atrial natriuretic peptide elevation in congestive heart failure in the human
2. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy
3. Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans; evidence for an exquisite dual natriuretic peptide system, ANP and BNP
4. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure
5. Localization, and mechanism of secretion of B-type natriuretic peptides in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
6. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis
7. Sympathoinhibitory effects of atrial natriuretic factor in normal humans
8. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure; beneficial effects on left ventricular function
9. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure
10. Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture
11. Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression
12. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro
13. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy; evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes
14. Transcriptional regulation during cardiac growth and development
15. Effects of interleukin-1β on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture
16. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
17. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy
18. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method
19. Brain natiuretic peptide as a cardiac hormone in essential hypertension